These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34980315)

  • 1. [Research progress of methylene blue in the treatment of sepsis and septic shock].
    Xue J; Lou X; Chen G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1384-1387. PubMed ID: 34980315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
    Saha BK; Burns SL
    Am J Med Sci; 2020 Oct; 360(4):329-337. PubMed ID: 32631574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.
    Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Manthati VL; Falck JR; Malik KU
    Nitric Oxide; 2013 Sep; 33():18-41. PubMed ID: 23684565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue administration in septic shock: a clinical trial.
    Preiser JC; Lejeune P; Roman A; Carlier E; De Backer D; Leeman M; Kahn RJ; Vincent JL
    Crit Care Med; 1995 Feb; 23(2):259-64. PubMed ID: 7532559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene blue for the treatment of septic shock.
    Paciullo CA; McMahon Horner D; Hatton KW; Flynn JD
    Pharmacotherapy; 2010 Jul; 30(7):702-15. PubMed ID: 20575634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylene blue, a soluble guanylyl cyclase inhibitor, reduces the sevoflurane minimum alveolar anesthetic concentration and decreases the brain cyclic guanosine monophosphate content in rats.
    Masaki E; Kondo I
    Anesth Analg; 1999 Aug; 89(2):484-9. PubMed ID: 10439772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
    Beasley D; McGuiggin M
    J Exp Med; 1994 Jan; 179(1):71-80. PubMed ID: 7505803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene blue reverses endotoxin-induced hypotension.
    Keaney JF; Puyana JC; Francis S; Loscalzo JF; Stamler JS; Loscalzo J
    Circ Res; 1994 Jun; 74(6):1121-5. PubMed ID: 8187278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue in the treatment of refractory shock from an amlodipine overdose.
    Jang DH; Nelson LS; Hoffman RS
    Ann Emerg Med; 2011 Dec; 58(6):565-7. PubMed ID: 21546119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion of methylene blue for septic shock.
    Brown G; Frankl D; Phang T
    Postgrad Med J; 1996 Oct; 72(852):612-4. PubMed ID: 8977944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene blue for distributive shock: a potential new use of an old antidote.
    Jang DH; Nelson LS; Hoffman RS
    J Med Toxicol; 2013 Sep; 9(3):242-9. PubMed ID: 23580172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene Blue to Neonatal Septic Shock treatment in neonate pigs
    Gonçalves-Ferri WA; Albuquerque AAS; de Castro RSAP; Ferreira CHF; Oharomari LK; Silva Lessa DF; Evora PRB
    Clinics (Sao Paulo); 2022; 77():100139. PubMed ID: 36459779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Septic shock and NO].
    Mitaka C
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():540-3. PubMed ID: 15506445
    [No Abstract]   [Full Text] [Related]  

  • 14. Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.
    Jing M; Ling GS; Bina S; Hart JL; Muldoon SM
    Eur J Pharmacol; 1998 Jan; 342(2-3):217-24. PubMed ID: 9548389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of methylene blue treatment for cardiovascular collapse.
    Lo JC; Darracq MA; Clark RF
    J Emerg Med; 2014 May; 46(5):670-9. PubMed ID: 24508113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation.
    Mink SN; Kasian K; Santos Martinez LE; Jacobs H; Bose R; Cheng ZQ; Light RB
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1724-35. PubMed ID: 18263714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal nitric oxide synthase and its interaction with soluble guanylate cyclase is a key factor for the vascular dysfunction of experimental sepsis.
    Nardi GM; Scheschowitsch K; Ammar D; de Oliveira SK; Arruda TB; Assreuy J
    Crit Care Med; 2014 Jun; 42(6):e391-400. PubMed ID: 24717470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of methylene blue in an experimental model of calcium channel blocker-induced shock.
    Jang DH; Donovan S; Nelson LS; Bania TC; Hoffman RS; Chu J
    Ann Emerg Med; 2015 Apr; 65(4):410-5. PubMed ID: 25441767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock.
    Zhang H; Rogiers P; Preiser JC; Spapen H; Manikis P; Metz G; Vincent JL
    Crit Care Med; 1995 Oct; 23(10):1711-21. PubMed ID: 7587237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Use of Methylene Blue in Catecholamine-Resistant Septic Shock: A Case Report and Short Literature Review.
    Pluta MP; Putowski Z; Czempik PF; Krzych ŁJ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.